Income statement revenue $256.15M (+31.7% YoY).Operating income $41.3M (+54.8% YoY).Pre-tax result $45.93M (+44.9% YoY).Net result $42.99M (+22.3% YoY).

Hypercortisolism Products: $208.58M (+7.3% YoY)
Lifyorli: $47.56M
Research and development: $53.89M (-10.9% YoY)
Selling, general and administrative: $156.9M (+51.1% YoY)
Other income: $4.63M (-7.7% YoY)
Income tax expense: $2.94M

Loading financials

Income statement income statement flow. Revenue $256.15M. Net result $42.99M.

Income statement revenue $256.15M (+31.7% YoY).Operating income $41.3M (+54.8% YoY).Pre-tax result $45.93M (+44.9% YoY).Net result $42.99M (+22.3% YoY).

Hypercortisolism Products: $208.58M (+7.3% YoY)
Lifyorli: $47.56M
Research and development: $53.89M (-10.9% YoY)
Selling, general and administrative: $156.9M (+51.1% YoY)
Other income: $4.63M (-7.7% YoY)
Income tax expense: $2.94M